A national clinical trial is underway to test a device that could help patients with chronic kidney disease during the ...
Clinical testing of children with suspected pediatric acute-onset neuropsychiatric syndrome does not help identify the ...
In its budget request, the agency proposed a way to speed up early drug testing and help smaller biotech firms. Elsewhere, two startups raised megarounds.
Scientists at Queen Mary, University of London, have announced a new machine-learning-based method for predicting the biological therapy, or biologic, most likely to successfully relieve symptoms for ...
As we start a new year, the clinical diagnostics industry finds itself at the intersection of rapid technological progress and significant uncertainty. I anticipate that continued innovation amid this ...
Morning Overview on MSN
UCLA develops low-cost blood test to flag multiple cancers and diseases
Researchers at the University of California, Los Angeles have published a new blood test designed to detect multiple cancers ...
Chris Hall, President and CEO, highlighted, "2025 was the year we validated our winning MRD strategy. 2026 is the year we expect to scale. Physicians increasingly trust our NeXT Personal test. Our ...
In the coming weeks, Quantum Biopharma will seek FDA permission for a clinical trial testing Lucid-MS, its therapy to slow myelin loss in MS.
Kymera Therapeutics has announced that Sanofi will advance their next-generation oral IRAK4 degrader, KT-485, into clinical testing, while opting not to pursue KT-474. Preclinical studies indicated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results